What is the efficacy of herbal medicine in the treatment of COVID-19 infection?

Cetinkaya, Erdem Atalay

doi:10.2478/rjr-2020-0023

Abstract

Currently, the cases continue to develop due to the rapid spread of COVID-19 via human-to-human transmission. Because there are no definitive anti COVID-19 drugs or vaccines available to treat this fatal infection, supporting medication to relieve the patient’s manifestations is generally the only choice. Because of the homology of COVID-19 pandemic and the previous SARS coronavirus outbreak in epidemiology, genomics, pathogenesis, and the widespread use of herbal medicine for the previous SARS outbreak, clinical data suggesting the beneficial impact of herbal medicine in the treatment of COVID-19 infections is discussed. 3-Chymotrypsin-protease inhibition, blocking RNA-dependent RNA polymerase activity, inhibition of helicase protein, inhibition of replication, inhibition of viral cell entry and immunomodulatory effect are the scientific reported anti-coronavirus effects of herb-derived compounds. The findings of a number of clinical experiences have shown that herbal medicine plays an important role in the treatment of COVID-19, giving new hope for COVID-19 prevention and control.

References

1. Coronavirus disease (COVID-19) Pandemic study. [Internet]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed April 1, 2020.
Search in Google Scholar Back to article
2. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;pii: dyaa033. DOI: 10.1093/ije/dyaa033. [Epub ahead of print]10.1093/ije/dyaa033
Search in Google Scholar Back to article
3. Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis. 2020;pii: S1473-3099(20)30129-8. DOI: 10.1016/S1473-3099(20)30129-8. [Epub ahead of print]10.1016/S1473-3099(20)30129-8
Search in Google Scholar Back to article
4. Leung PC. The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis. Am J Chin Med. 2007;35(4):575-81. DOI: 10.1142/S0192415X07005077.10.1142/S0192415X07005077
Search in Google Scholar Back to article
5. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361(9374):2045-6. DOI: 10.1016/s0140-6736(03)13615-x.10.1016/S0140-6736(03)13615-X
Search in Google Scholar Back to article
6. Wu T, Yang X, Zeng X, Poole P. Traditional Chinese medicine in the treatment of acute respiratory tract infections. Respir Med. 2008;102(8):1093-8. DOI: 10.1016/j.rmed.2008.03.015.10.1016/j.rmed.2008.03.015713491918590956
Search in Google Scholar Back to article
7. Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830(6):3670-95. DOI: 10.1016/j.bbagen.2013.02.008.10.1016/j.bbagen.2013.02.008367286223428572
Search in Google Scholar Back to article
8. Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARSCoV-2): A review and perspective. Int J Biol Sci. 2020;16(10):1708-17. DOI: 10.7150/ijbs.45538.10.7150/ijbs.45538709803632226288
Search in Google Scholar Back to article
9. Luo W, Su X, Gong S, Qin Y, Liu W, Li J, et al. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Bioscience Trends. 2009;3(4):124-6.
Search in Google Scholar Back to article
10. Lau KM, Lee KM, Koon CM, Cheung CSF, Lau CP, Ho HM, et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol. 2008;118(1):79-85. DOI: 10.1016/j.jep.2008.03.018.10.1016/j.jep.2008.03.018712638318479853
Search in Google Scholar Back to article
11. Gong SJ, Su XJ, Yu HP, Li J, Qin YJ, Xu Q, et al. A study on anti-SARS-CoV 3CL protein of flavonoids from litchi chinensis sonn core. Chinese Pharmacological Bulletin. 2008;24:699-700.
Search in Google Scholar Back to article
12. Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68(1):36-42.10.1016/j.antiviral.2005.07.002711432116115693
Search in Google Scholar Back to article
13. Jo S, Kim S, Shin DH, Kim MS. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem. 2020;35(1):145-51. DOI: 10.1080/14756366.2019.1690480.10.1080/14756366.2019.1690480688243431724441
Search in Google Scholar Back to article
14. Fung KP, Leung PC, Tsui KWS, Wan CCD, Wong KB, Waye MYM, et al. Immunomodulatory activities of the herbal formula Kwan Du Bu Fei Dang in healthy subjects: a randomised, double-blind, placebo-controlled study. Hong Kong Med J. 2011;17 Suppl 2:41-3.
Search in Google Scholar Back to article
15. Yu MS, Lee J, Lee JM, Kim Y, Chin YW, Jee JG, et al. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg Med Chem Lett. 2012;22(12):4049-54. DOI: 10.1016/j.bmcl.2012.04.081.10.1016/j.bmcl.2012.04.081712743822578462
Search in Google Scholar Back to article
16. Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YS, et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A. 2004;101(27):10012-7. DOI: 10.1073/pnas.0403596101.10.1073/pnas.040359610145415715226499
Search in Google Scholar Back to article
17. Kuhn JH, Radoshitzky SR, Li W, Wong SK, Choe H, Farzan M. The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy. In: Holzenburg A, Bogner E, editors. New Concepts of Antiviral Therapy. Boston, MA: Springer US; 2006, p.397-418.10.1007/978-0-387-31047-3_15
Search in Google Scholar Back to article
18. Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562-9. DOI: 10.1038/s41564-020-0688-y.10.1038/s41564-020-0688-y709543032094589
Search in Google Scholar Back to article
19. Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2007;74(2):92-101. DOI: 10.1016/j.antiviral.2006.04.014.10.1016/j.antiviral.2006.04.014711433216730806
Search in Google Scholar Back to article
20. Deng YF, Aluko RE, Jin Q, Zhang Y, Yuan LJ. Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm Biol. 2012;50(4):401-6. DOI: 10.3109/13880209.2011.608076.10.3109/13880209.2011.60807622136493
Search in Google Scholar Back to article
21. Takahashi S, Yoshiya T, Yoshizawa-Kumagaye K, Sugiyama T. Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomed Res. 2015;36(3):219-24. DOI: 10.2220/biomedres.36.219.10.2220/biomedres.36.21926106051
Search in Google Scholar Back to article
22. Cheng PW, Ng LT, Chiang LC, Lin CC. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol. 2006;33(7):612-6.10.1111/j.1440-1681.2006.04415.x716203116789928
Search in Google Scholar Back to article
23. Chen CJ, Michaelis M, Hsu HK, Tsai CC, Yang KD, Wu YC, et al. Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol. 2008;120(1):108-11.10.1016/j.jep.2008.07.048712724818762235
Search in Google Scholar Back to article
24. Chan MC, Chan RW, Mok CK, Mak NK, Wong RN. Indirubin-3’-oxime as an antiviral and immunomodulatory agent in treatment of severe human influenza virus infection. Hong Kong Med J. 2018;24 Suppl 6(5):45-7.
Search in Google Scholar Back to article
25. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14(1):69-71. DOI: 10.5582/bst.2020.01020.10.5582/bst.2020.0102031996494
Search in Google Scholar Back to article
26. AminJafari A, Ghasemi S. The possible of immunotherapy for COVID-19: A systematic review. Int Immunopharmacol. 2020;83:106455. Published online 2020 Apr 2. DOI: 10.1016/j.intimp.2020.106455.10.1016/j.intimp.2020.106455712819432272396
Search in Google Scholar Back to article

What is the efficacy of herbal medicine in the treatment of COVID-19 infection?

Abstract

Paradigm

My account